eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 1 : 52-60 doi: ijmmas.2006.52.60
Research Article
Ischemia and Tumor Pathogenesis as Strictly Characterized by Inflammatory Responsiveness of Cells and Tissues
Published
Sept. 30, 2005
Abstract

Integral  ischemic  and  inflammatory  conditioning  influences  in  determining  responsiveness  of  cells  and  tissues  in  transforming  pathology  ranging  from  infection  to  neoplasia  to  tissue   atrophy would  in  various  ways  perhaps  help  delineate  pathways  of  pathologic  progressiveness   beyond simple  etiologic  considerations.    Indeed,   responsiveness   of   injured   cells,  tissues  and  organs  as  an inflammatory  series  of  pathways  in  a  conditioning  setting  induced  by  variable states of pre-existing or coincident  ischemia  might  perhaps  help  account  for  the  development of different patterns of pathologic progressiveness  in  cells and tissues.  Indeed, a system of neoplastic transformation would be distinct from one  of  active infection, of progressive tissue atrophy, or of evolving frank infarction, simply in terms of the nature  of  the   responsiveness  pathways  as  developing  in  injured  cells  and tissues in the first instance.  Ischemic  effect  would  itself  perhaps  prove  a  prime  mode  of  influence in determining the nature of such responsiveness  of  cells,  tissues,  and  organs  when  injured  in  ultimately    distinguishing     between    a pattern  of  active  infection  versus  one  of  neoplasia  or  of  atrophy  in  a  progressive  setting  of disease evolution and transformation.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Assessment of Research Competency Among Medical Students: Knowledge, Skills, Attitudes, and Educational Implications
22-27
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.